Thrombin cleavable linker with XTEN and its uses thereof
AU2026205478A1Pending Publication Date: 2026-07-30BIOVERATIV THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- BIOVERATIV THERAPEUTICS INC
- Filing Date
- 2026-07-09
- Publication Date
- 2026-07-30
Smart Images

Figure 00000140_0000 
Figure 00000140_0001 
Figure 00000142_0000
Abstract
The present invention provides a chimeric molecule comprising a VWF protein fused to a heterologous moiety via a VWF linker. The invention provides an efficient VWF linker that can be cleaved in the presence of thrombin. The chimeric molecule can further comprise a polypeptide chain comprising a FVIII protein and a second heterologous moiety, wherein the chain comprising the VWF protein and the chain comprising the FVIII protein are associated with each other. The invention also includes nucleotides, vectors, host cells, methods of using the chimeric proteins. 20 26 20 54 78 09 J ul 2 02 6 2 0 2 6 2 0 5 4 7 8 0 9 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art